Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Teclistamab (anti-CD3 & BCMA) is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab (anti-CD3 & BCMA) can be used in studies of diseases related to multiple myeloma (MM).
Teclistamab (anti-CD3&BCMA) (Ab175669) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3&BCMA with Teclistamab (anti-CD3&BCMA) (Ab175669) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Teclistamab (anti-CD3&BCMA) (Ab175669) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3&BCMA (red) with Teclistamab (anti-CD3&BCMA) (Ab175669) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Teclistamab (anti-CD3&BCMA) (Ab175669) - ELISA
Immobilized Recombinant Human CD3 protein (rp175910) at 1.0 μg/mL can bind Teclistamab (anti-CD3&BCMA) (Ab175669) with the EC50 of 99.33 ng/mL.
Teclistamab (anti-CD3&BCMA) (Ab175669) - ELISA
Immobilized Recombinant Human BCMA/TNFRSF17 protein (rp169554) at 1.0 μg/mL can bind Teclistamab (anti-CD3&BCMA) (Ab175669) with the EC50 of 6.582 ng/mL.
Teclistamab (anti-CD3&BCMA) (Ab175669) - SEC
The purity of Teclistamab (anti-CD3&BCMA) (Ab175669) is more than 95% verified by HPLC.
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →
